Opioids Market Size Worth $29.4 Billion By 2026 On Accounts Of Rising Prevalence Of Chronic Pain Due To Various Diseases | Grand View Research, Inc.

Posted on
by

Opioids Market Size Worth $29.4 Billion By 2026 On Accounts Of Rising Prevalence Of Chronic Pain Due To Various Diseases | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
According to the report published by Grand View Research, Inc., factors such as increasing prevalence of chronic pain due to diseases like cancer, post-surgery procedures, fibromyalgia and arthritis are going to keep the market growth rate up and running for the coming years.

According to a report, “Opioids Market Size, Share & Trends Analysis Report By Product (IR/ Short-acting, ER/Long-acting), By Application (Pain Relief, Anesthesia), By Region, And Segment Forecasts, 2019 – 2026”, published by Grand View Research, Inc. The global opioids market size is estimated to reach USD 29.4 billion by 2026, according to a new report by Grand View Research, Inc., expanding at a CAGR of 1.8% over the forecast period. Growing geriatric population, coupled with increasing focus on palliative care, is estimated to drive the market. Moreover, increasing geographical expansions by market players is expected to fuel growth.

Substantial rise in road accidents and trauma, coupled with constantly increasing cases of surgical procedures, is driving demand for opioid-based pain management solutions. Based on region, North America led the market in 2018 with a share of 55.5% in terms of revenue. One of the major reasons for its dominance is rising geriatric population with terminal conditions, such as rheumatoid arthritis. However recently it was observed that opioid addiction in the country was rising at a grave rate. Hence, drug abuse has been declared a “public health emergency” in U.S. and this is likely to limit market growth in North America.

The federal government is calling on pharmaceutical companies to stop marketing opioids. For instance, Purdue Pharma has stopped marketing its opioids in Canada, thereby limiting the growth of the North America market. The company has, in fact, shifted its focus to other regions, such as Asia Pacific, to retain its hold in the market. APAC is likely to witness the fastest growth in the coming years.

U.S. opioids market size, by product, 2014 - 2026 (USD Billion)

Further key findings from the study suggest:

  • Major companies are resolving their legal issues with government and turning on a new page. For example, in October 2020, Purdue Pharma L.P. announced that it has entered into an agreement with the United States Department of Justice (DOJ) to resolve multi-year civil and criminal investigations into the company’s past marketing practices related to its opioid medicines.

  • In 2018, the Drug Enforcement Administration raised production quotas for drug manufacturers Fresenius Kabi and West-Ward Pharmaceuticals to mitigate the shortage of opioid injectables, and fill the void created by Pfizer.

  • On the basis of product type, extended release was the largest product segment in 2018 due to its high usage in chronic pain management

  • Cancer pain was the largest pain relief segment in 2018 owing to global increase in prevalence of cancer

  • On the basis of region, North America was the largest regional market in 2018, driven by presence of key players and highest use of prescription opioids

  • Europe was the second-largest regional market in 2018, primarily fueled by growing geriatric population

  • Asia Pacific is expected to witness the fastest growth over the forecast period due to increase in geriatric population, coupled with shifting focus of key players towards this region in order to strengthen their position

  • Some of the key players are Purdue Pharma L.P; West-Ward Pharmaceuticals Corporation; Allergan; Pfizer, Inc.; Janssen Pharmaceuticals, Inc.; Egalet Corporation; and Sun Pharmaceutical Industries Limited. Most key players are focusing on entering untapped regions and expanding their product portfolios.

“Would you Like/Try a Sample Report” Click the link below:https://www.grandviewresearch.com/industry-analysis/opioids-market/request/rs1

Grand View Research has segmented the global opioids market on the basis of product, application, and region:

Opioids Product Outlook (Revenue, USD Billion, 2014 – 2026)

  • Immediate-release/Short-acting

    • Immediate-release/Short-acting Opioid, by Product

  • Codeine

  • Oxycodone

  • Hydrocodone

  • Fentanyl

  • Morphine

  • Hydroxymorphone

  • Oxymorphone

  • Propoxyphene

  • Other IR

  • Immediate-release/Short-acting Opioid, by Application

    • Pain Relief

    • Anesthesia

    • Cough Suppression

    • Diarrhea Suppression

    • De-addiction

  • Extended-release/Long-acting

    • Extended-release/Long-acting Opioid, by Product

      • Oxycodone

      • Hydrocodone

      • Methadone

      • Fentanyl

      • Morphine

      • Oxymorphone

      • Tapentadol

      • Buprenorphine

      • Hydromorphone

      • Other ER

    • Extended-release/Long-acting Opioid, by Application

      • Pain Relief

      • Anesthesia

      • Cough Suppression

      • Diarrhea Suppression

      • De-addiction

Opioids Application Outlook (Revenue, USD Billion, 2014 – 2026)

  • Pain Relief

    • Cancer pain

    • Postoperative pain management

    • Low-back pain

    • Orthopedic

    • Neuropathic pain

    • Fibromyalgia

  • Anesthesia

  • Cough Suppression

  • Diarrhea Suppression

  • De-addiction

Opioids Regional Outlook (Revenue, USD Billion, 2014 – 2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Singapore

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • UAE

    • Saudi Arabia

List of Key Players of Opioids Market
• Purdue Pharma L.P.
• Allergan
• West-Ward Pharmaceuticals Corporation
• Janssen Pharmaceuticals, Inc.
• Pfizer, Inc.
• Egalet Corporation
• Sun Pharmaceutical Industries Limited

Have Any Query? Ask Our Experts for More Details on Report:https://www.grandviewresearch.com/inquiry/5024/ibb

Browse Related Report @

Opioid Use Disorder Market – https://www.grandviewresearch.com/industry-analysis/opioid-use-disorder-market

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research is a market research and consulting company that offers market research reports, syndicated and customized reports. The company is headquartered in San Francisco, California. It offers client engagement for business consulting and market intelligence from various domains. The clientele is based across various countries with queries coming from more than 50 industries worldwide.
Grand View Research helps its clients to make informed decisions by helping them understand current trends and scenarios. Every year Grand View Research accomplishes more than 300 multi-country market studies to optimize consulting for clients.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/opioids-market